Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > USA News Group

<< Previous

Bullboard Posts

Next >>

Comment by lonc17on Aug 31, 2023 10:18pm

192 Views

Post# 35615109

RE:RE:USA News Group

It is disgraceful that Oncolytics chooses to promote itself in such a manner.

I've been long this stock for twenty years, but if I was a new investor having a look at ONC I would consider them a pump and dump if I stumbled upon these paid for advertisements.

Oh wait, maybe they are a pump and dump.

Gee, it only took me 20 years to figure it out.

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports